These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5999895)

  • 21. Interspecies differences in coagulation profile.
    Siller-Matula JM; Plasenzotti R; Spiel A; Quehenberger P; Jilma B
    Thromb Haemost; 2008 Sep; 100(3):397-404. PubMed ID: 18766254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reactivity of the blood coagulation system in experimental adrenal insufficiency].
    Petrishchev NN
    Vestn Khir Im I I Grek; 1973 Apr; 110(4):37-41. PubMed ID: 4712360
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of estrogens on blood clotting.
    Jarzyna A; Wróblewski M
    Pol Med J; 1967; 6(3):754-9. PubMed ID: 6038099
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood coagulation: hemostasis and thrombin regulation.
    Tanaka KA; Key NS; Levy JH
    Anesth Analg; 2009 May; 108(5):1433-46. PubMed ID: 19372317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of soy bean trypsin inhibitor on fibrin clot lysis.
    Egeblad K
    Thromb Diath Haemorrh; 1966 May; 15(3):542-53. PubMed ID: 6011258
    [No Abstract]   [Full Text] [Related]  

  • 26. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
    Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
    Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
    Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
    J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species.
    Bock PE; Srinivasan KR; Shore JD
    Biochemistry; 1981 Dec; 20(25):7258-66. PubMed ID: 6797471
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin-induced intravascular coagulation: role in vascular injury.
    Kaplan JE; Malik AB
    Semin Thromb Hemost; 1987 Oct; 13(4):398-415. PubMed ID: 3321435
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thrombelastographic data in an experimental study of the action of fibrinolytic agents].
    Izmaĭlova EF; Slobozhankina IK
    Patol Fiziol Eksp Ter; 1966; 10(4):18-22. PubMed ID: 5237733
    [No Abstract]   [Full Text] [Related]  

  • 32. [Trial to influence by drugs the post-irradiation disorders of blood coagulation].
    Klír P; Pospísil J; Skala E; Dienstbier Z
    Vnitr Lek; 1971 Oct; 17(10):937-42. PubMed ID: 5110477
    [No Abstract]   [Full Text] [Related]  

  • 33. Occult intravascular clotting by means of intravenous injection of thrombin.
    QUICK AJ; HUSSEY CV; HARRIS J; PETERS K
    Am J Physiol; 1959 Oct; 197():791-4. PubMed ID: 14435533
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hemostasis and maintenange of the organism vitamin C].
    Byshevskiĭ ASh; Mataev SI; Rudzevich AIu; Shpovalova EM
    Vopr Pitan; 2008; 77(3):21-8. PubMed ID: 18669327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation activation by lipopolysaccharides.
    Stief TW
    Clin Appl Thromb Hemost; 2009; 15(2):209-19. PubMed ID: 18160570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of ellagic acid on the thrombin-induced hemorrhagic syndrome in the rat.
    Cliffton EE; Girolami A; Agostino D
    Blood; 1966 Aug; 28(2):253-7. PubMed ID: 5913054
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanism of the congestion of lymph nodes induced by ellagic acid in rats.
    Damas J; Remacle-Volon G; Adam A
    Agents Actions; 1987 Dec; 22(3-4):202-8. PubMed ID: 3445816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
    Cirillo R; Lippi A; Subissi A; Agnelli G; Criscuoli M
    Thromb Haemost; 1996 Sep; 76(3):384-92. PubMed ID: 8883275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1263-71. PubMed ID: 16146462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models.
    Furugohri T; Shiozaki Y; Muramatsu S; Honda Y; Matsumoto C; Isobe K; Sugiyama N
    Eur J Pharmacol; 2005 May; 514(1):35-42. PubMed ID: 15878322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.